EcoDrugPlus

Alpha-Synuclein-Like

Ensembl ID : ENSPNYG00000008293
Gene Symbol: LOC102212091
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSPNYG00000021111
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amylase Alpha 1c

Ensembl ID : ENSPNYG00000006684
Gene Symbol: AMY1C
4 Cross references
213 Possible Orthologues:

Amyloid Beta A4 Protein-Like

Ensembl ID : ENSPNYG00000019022
Gene Symbol: LOC102215690
3 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSPNYG00000016921
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSPNYG00000017954
Gene Symbol: AR
3 Cross references
212 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSPNYG00000005957
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Antithrombin-Iii-Like

Ensembl ID : ENSPNYG00000024050
Gene Symbol: LOC102209932
2 Cross references
198 Possible Orthologues:

Apelin Receptor A-Like

Ensembl ID : ENSPNYG00000006632
Gene Symbol: LOC102201802
3 Cross references
171 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSPNYG00000019699
Gene Symbol: APH1A
3 Cross references
190 Possible Orthologues:

Apoptosis Regulator Bcl-2-Like

Ensembl ID : ENSPNYG00000021903
Gene Symbol: LOC102199243
2 Cross references
168 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSPNYG00000023940
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).